{"gao_id": "GAO-07-49", "published": "2006-11-17T13:00:00Z", "released": "2006-12-19T08:00:00Z", "summary": "", "title": "New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts", "topics": ["Research and development costs", "Pharmaceutical industry", "Pharmacological research", "Research and development", "Policy evaluation", "Safety regulation", "Drugs", "Prescription drugs", "Drug testing", "Health Care", "Product evaluation"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-07-49", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-07-49-highlights.pdf"}, {"title": "Full Report (52 pages)", "url": "https://www.gao.gov/assets/gao-07-49.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a253731.html"}]}